Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-16 Sale | 2023-06-21 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 1,655 | $14.4 | $23,835 | 378,613 (Indirect Direct) | View |
| 2023-02-16 Sale | 2023-02-17 4:04 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 1,370 | $15.1 | $20,686 | 446,168 (Indirect Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:06 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 2,403 | $21.24 | $51,043 | 365,150 (Indirect Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:34 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 1,768 | $10.75 | $19,006 | 367,553 (Indirect Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 1,366 | $9.05 | $12,362 | 369,321 (Indirect Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 508 | $48.87 | $24,826 | 388,987 (Indirect Direct) | View |
| 2019-12-12 Sale | 2019-12-13 5:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 31,029 | $60 | $1,861,740 | 115,520 (Indirect Direct) | View |
| 2019-12-09 Sale | 2019-12-11 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 152,927 | $55 | $8,410,985 | 404,922 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-15 Option Award | 2023-02-17 4:04 pm | N/A 2033-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 82,388 | $0 | 446,168 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 102,500 | $0 | 452,687 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:00 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 93,365 | $0 | 432,452 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 7:00 pm | N/A 2031-02-15 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 61,000 | $0 | 388,987 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 4:00 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 9,029 | $1.89 | 328,495 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 4:00 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 9,029 | $0 | 328,495 (Direct) | View |
| 2020-07-22 Exercise | 2020-07-24 4:00 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 130,000 | $1.89 | 328,495 (Direct) | View |
| 2020-07-22 Exercise | 2020-07-24 4:00 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 130,000 | $0 | 328,495 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A 2030-02-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 49,230 | $0 | 231,656 (Direct) | View |
| 2020-01-16 Exercise(A) | 2020-01-22 4:20 pm | N/A 2026-09-26 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 10,106 | $0 | 4,944 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A 2026-09-26 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 66,906 | $0 | 306,687 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 10,106 | $3.95 | 306,687 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 56,800 | $6.13 | 306,687 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 152,927 | $1.89 | 404,922 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 152,927 | $0 | 404,922 (Direct) | View |